Michael J. Dwyer
Keine laufenden Positionen mehr
Karriereverlauf von Michael J. Dwyer
Ehemalige bekannte Positionen von Michael J. Dwyer
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Vertrieb & Marketing | 01.05.2006 | 03.02.2009 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Vertrieb & Marketing | 01.11.1999 | 01.10.2005 |
| Caremark Therapeutic Services | Vertrieb & Marketing | 01.01.1993 | 01.01.1999 |
| NOVO NORDISK A/S | Vertrieb & Marketing | - | - |
Ausbildung von Michael J. Dwyer
| Pepperdine University | Masters Business Admin |
| University of Dayton | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Dänemark | 2 |
Operativ
| Sales & Marketing | 4 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| Private Unternehmen | 3 |
|---|---|
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
| Caremark Therapeutic Services |
- Börse
- Insiders
- Michael J. Dwyer
- Erfahrung
